Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cellular response to phenylpropanoid	UGT3A1 UGT3A2	3.70e-05	2	126	2	GO:1905546
GeneOntologyBiologicalProcess	cellular response to hydroxyisoflavone	UGT3A1 UGT3A2	3.70e-05	2	126	2	GO:0071413
GeneOntologyBiologicalProcess	cellular response to genistein	UGT3A1 UGT3A2	3.70e-05	2	126	2	GO:0071412
GeneOntologyCellularComponent	axonal growth cone	BOC CLASP2 TAOK2 NEO1	1.60e-04	45	127	4	GO:0044295
GeneOntologyCellularComponent	UDP-N-acetylglucosamine transferase complex	UGT3A1 UGT3A2	2.18e-04	4	127	2	GO:0043541
GeneOntologyCellularComponent	organelle membrane contact site	C2CD2L ESYT3 VPS13A TMCC1	4.00e-04	57	127	4	GO:0044232
Domain	Ig_I-set	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	7.36e-09	190	128	12	IPR013098
Domain	I-set	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	7.36e-09	190	128	12	PF07679
Domain	IGc2	BOC FCRL2 FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	6.62e-07	235	128	11	SM00408
Domain	Ig_sub2	BOC FCRL2 FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	6.62e-07	235	128	11	IPR003598
Domain	Ig_V-set	BOC FCRL2 AXL VSIG10 CADM2 KIRREL3 SIGLEC7 ROBO2 IGSF9B	9.44e-06	199	128	9	IPR013106
Domain	LRR_1	CNTRL PIDD1 LRRC58 PXDN LGI2 PHLPP1 FLRT2 NXF1 LGI1	2.03e-05	219	128	9	PF00560
Domain	LRR_TYP	CNTRL PIDD1 LRRC58 PXDN LGI2 PHLPP1 FLRT2 LGI1	3.02e-05	177	128	8	SM00369
Domain	Leu-rich_rpt_typical-subtyp	CNTRL PIDD1 LRRC58 PXDN LGI2 PHLPP1 FLRT2 LGI1	3.02e-05	177	128	8	IPR003591
Domain	IG	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	3.31e-05	421	128	12	SM00409
Domain	Ig_sub	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	3.31e-05	421	128	12	IPR003599
Domain	V-set	BOC FCRL2 AXL VSIG10 CADM2 KIRREL3 SIGLEC7 IGSF9B	3.98e-05	184	128	8	PF07686
Domain	-	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN CSF2RB ATF7IP ROBO2 IGSF9B FLRT2	4.93e-05	663	128	15	2.60.40.10
Domain	FN3	BOC AXL NEO1 CSF2RB ATF7IP ROBO2 IGSF9B FLRT2	6.92e-05	199	128	8	PS50853
Domain	FN3_dom	BOC AXL NEO1 CSF2RB ATF7IP ROBO2 IGSF9B FLRT2	9.75e-05	209	128	8	IPR003961
Domain	Ig-like_fold	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN CSF2RB ATF7IP ROBO2 IGSF9B FLRT2	9.97e-05	706	128	15	IPR013783
Domain	Leu-rich_rpt	CNTRL PIDD1 LRRC58 PXDN LGI2 PHLPP1 FLRT2 NXF1 LGI1	1.06e-04	271	128	9	IPR001611
Domain	fn3	BOC AXL NEO1 CSF2RB ROBO2 IGSF9B FLRT2	1.27e-04	162	128	7	PF00041
Domain	IG_LIKE	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	1.43e-04	491	128	12	PS50835
Domain	Ig_2	FCRL2 KIRREL3 NEO1 SIGLEC7 IGSF9B	1.45e-04	73	128	5	PF13895
Domain	LRR_8	PIDD1 LRRC58 PXDN LGI2 PHLPP1 FLRT2 LGI1	1.78e-04	171	128	7	PF13855
Domain	Ig-like_dom	BOC FCRL2 AXL FSTL4 VSIG10 CADM2 KIRREL3 NEO1 SIGLEC7 PXDN ROBO2 IGSF9B	1.79e-04	503	128	12	IPR007110
Domain	FN3	BOC AXL NEO1 CSF2RB ROBO2 IGSF9B FLRT2	2.88e-04	185	128	7	SM00060
Domain	-	CNTRL PIDD1 LRRC58 PXDN LGI2 PHLPP1 FLRT2 NXF1 LGI1	3.72e-04	321	128	9	3.80.10.10
Domain	L_dom-like	CNTRL PIDD1 LRRC58 PXDN LGI2 PHLPP1 FLRT2 NXF1 LGI1	4.36e-04	328	128	9	IPR032675
Domain	EPTP	LGI2 LGI1	6.87e-04	6	128	2	PF03736
Domain	EPTP	LGI2 LGI1	6.87e-04	6	128	2	IPR005492
Domain	GGT_peptidase	GGTLC2 GGT1	9.57e-04	7	128	2	IPR000101
Domain	G_glu_transpept	GGTLC2 GGT1	9.57e-04	7	128	2	PF01019
Domain	EAR	LGI2 LGI1	9.57e-04	7	128	2	IPR009039
Domain	G_GLU_TRANSPEPTIDASE	GGTLC2 GGT1	9.57e-04	7	128	2	PS00462
Domain	EAR	LGI2 LGI1	9.57e-04	7	128	2	PS50912
Domain	MacrogloblnA2_thiol-ester-bond	CPAMD8 C3	1.27e-03	8	128	2	IPR019565
Domain	Thiol-ester_cl	CPAMD8 C3	1.27e-03	8	128	2	PF10569
Domain	MacrogloblnA2_CS	CPAMD8 C3	1.27e-03	8	128	2	IPR019742
Domain	A2M_N_2	CPAMD8 C3	1.27e-03	8	128	2	SM01359
Domain	-	CPAMD8 C3	1.27e-03	8	128	2	2.60.40.690
Domain	A2M_recep	CPAMD8 C3	1.27e-03	8	128	2	SM01361
Domain	A2M	CPAMD8 C3	1.27e-03	8	128	2	SM01360
Domain	ig	BOC FCRL2 AXL FSTL4 VSIG10 SIGLEC7	1.99e-03	190	128	6	PF00047
Domain	Immunoglobulin	BOC FCRL2 AXL FSTL4 VSIG10 SIGLEC7	1.99e-03	190	128	6	IPR013151
Domain	A2M	CPAMD8 C3	2.02e-03	10	128	2	PF00207
Domain	A2M_N_2	CPAMD8 C3	2.02e-03	10	128	2	IPR011625
Domain	A2M_comp	CPAMD8 C3	2.02e-03	10	128	2	IPR011626
Domain	A2M_recep	CPAMD8 C3	2.02e-03	10	128	2	PF07677
Domain	A2M_comp	CPAMD8 C3	2.02e-03	10	128	2	PF07678
Domain	A2M_N	CPAMD8 C3	2.02e-03	10	128	2	PF01835
Domain	A2M_N	CPAMD8 C3	2.02e-03	10	128	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	CPAMD8 C3	2.02e-03	10	128	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	CPAMD8 C3	2.02e-03	10	128	2	PS00477
Domain	A2M_N_2	CPAMD8 C3	2.02e-03	10	128	2	PF07703
Domain	Macroglobln_a2	CPAMD8 C3	2.02e-03	10	128	2	IPR001599
Domain	LRR	CNTRL PIDD1 LRRC58 PXDN PHLPP1 NXF1	2.64e-03	201	128	6	PS51450
Domain	C2-set_2	CADM2 KIRREL3 SIGLEC7	2.77e-03	41	128	3	PF08205
Domain	CD80_C2-set	CADM2 KIRREL3 SIGLEC7	2.77e-03	41	128	3	IPR013162
Domain	-	CPAMD8 C3	2.94e-03	12	128	2	1.50.10.20
Domain	Cys-rich_flank_reg_C	PXDN LGI2 FLRT2 LGI1	3.41e-03	90	128	4	IPR000483
Domain	LRRCT	PXDN LGI2 FLRT2 LGI1	3.41e-03	90	128	4	SM00082
Domain	CarboxyPept_regulatory_dom	CPN1 AEBP1	3.46e-03	13	128	2	IPR014766
Domain	-	CPN1 AEBP1	3.46e-03	13	128	2	2.60.40.1120
Domain	uDENN	SBF2 DENND5A	4.02e-03	14	128	2	SM00800
Domain	-	CLASP2 FRYL TEX10 IFRD2 PDS5A TNPO3	4.30e-03	222	128	6	1.25.10.10
Domain	uDENN	SBF2 DENND5A	4.62e-03	15	128	2	PF03456
Domain	GRAM	TBC1D8 SBF2	5.25e-03	16	128	2	SM00568
Domain	DENN	SBF2 DENND5A	5.25e-03	16	128	2	SM00799
Domain	DENN	SBF2 DENND5A	5.25e-03	16	128	2	PF02141
Domain	dDENN	SBF2 DENND5A	5.25e-03	16	128	2	PF03455
Domain	UDENN	SBF2 DENND5A	5.25e-03	16	128	2	PS50946
Domain	DDENN	SBF2 DENND5A	5.25e-03	16	128	2	PS50947
Domain	dDENN	SBF2 DENND5A	5.25e-03	16	128	2	SM00801
Domain	dDENN_dom	SBF2 DENND5A	5.25e-03	16	128	2	IPR005112
Domain	uDENN_dom	SBF2 DENND5A	5.25e-03	16	128	2	IPR005113
Domain	DENN	SBF2 DENND5A	5.25e-03	16	128	2	PS50211
Domain	DENN_dom	SBF2 DENND5A	5.25e-03	16	128	2	IPR001194
Domain	Gal_mutarotase_SF_dom	LGI2 LGI1	5.93e-03	17	128	2	IPR011013
Domain	CarboxyPept-like_regulatory	CPN1 AEBP1	5.93e-03	17	128	2	IPR008969
Domain	Terpenoid_cyclase/PrenylTrfase	CPAMD8 C3	6.64e-03	18	128	2	IPR008930
Domain	Zn_pept	CPN1 AEBP1	6.64e-03	18	128	2	SM00631
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NDOR1 SIPA1L3 KSR2 MED14 CLASP2 FRYL ITGA3 ADCY9 C2CD2L TAOK2 HIVEP3 PWWP2B SCAP SBF2 IFRD2 MICAL3 DENND5A SPEN MYRF TNPO3 MED13	9.51e-10	1105	130	21	35748872
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATF7 CPAMD8 SIPA1L3 PCDH11Y AFF3 KSR2 FRMPD1 CLASP2 FRYL HIVEP3 USP10 PWWP2B PXDN SBF2 MICAL3 IGSF9B DENND5A SAP130 TSEN15 TMCC1 DOP1A	1.61e-07	1489	130	21	28611215
Pubmed	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.	CPN1 GGTLC2 GGT1 STAT4 MLIP MICAL3	2.20e-07	68	130	6	22001757
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SIPA1L3 HIVEP3 PARP4 SCAP SBF2 PDS5A MICAL3 FLRT2 TMCC1 UNC80 DOP1A	2.65e-06	493	130	11	15368895
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	BOC FCRL2 AXL FSTL4 CADM2 KIRREL3 PXDN	2.73e-06	162	130	7	25826454
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PRDX4 SIPA1L3 MED14 CLASP2 TSPYL1 TEX10 C2CD2L TAOK2 USP10 PHC3 STRN PXDN IFRD2 PDS5A SPEN YME1L1 TMCC1 MED13 NXF1	3.15e-06	1497	130	19	31527615
Pubmed	Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes.	UGT3A1 UGT3A2	1.39e-05	2	130	2	22621930
Pubmed	Similarity of molecular phenotype between known epilepsy gene LGI1 and disease candidate gene LGI2.	LGI2 LGI1	1.39e-05	2	130	2	20863412
Pubmed	Expression of the third complement component (C3) and carboxypeptidase N small subunit (CPN1) during mouse embryonic development.	CPN1 C3	1.39e-05	2	130	2	15177117
Pubmed	A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma.	AFF3 BCL2	1.39e-05	2	130	2	18622426
Pubmed	BCL2 and BCL3 are recurrent translocation partners of the IGH locus.	BCL2 BCL3	1.39e-05	2	130	2	18940474
Pubmed	Vitamin D enhances glucocorticoid action in human monocytes: involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14.	MED14 CSF2RB	1.39e-05	2	130	2	23572530
Pubmed	ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy.	LGI2 LGI1	1.39e-05	2	130	2	15857855
Pubmed	Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.	AXL BCL2	1.39e-05	2	130	2	21068757
Pubmed	Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.	AXL MAP1LC3A	1.39e-05	2	130	2	31094090
Pubmed	Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.	STRN NUP155 TNPO3 NXF1	1.53e-05	40	130	4	37516964
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	CDHR1 PCDH11Y KIRREL3 LGI2 IGSF9B	2.43e-05	91	130	5	28558017
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ASAP3 MAP1LC3A PHC3 FAM193A NUP155 AEBP1 IGSF9B SPEN SAP130	3.66e-05	430	130	9	35044719
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CNTRL CLASP2 AK8 ADCY9 NEO1 NUP155 ATF7IP VPS13A PDS5A FLRT2 TACC3 SPEN	3.70e-05	777	130	12	35844135
Pubmed	IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.	BCL2 BCL3	4.15e-05	3	130	2	30575108
Pubmed	Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux.	PCDH11Y ROBO2	4.15e-05	3	130	2	17357069
Pubmed	Human lung expresses unique gamma-glutamyl transpeptidase transcripts.	GGTLC2 GGT1	4.15e-05	3	130	2	7689219
Pubmed	Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.	MAP1LC3A BCL2	4.15e-05	3	130	2	23624503
Pubmed	Mammalian Hippo kinase pathway is downregulated by BCL-2 via protein degradation.	SAV1 BCL2	4.15e-05	3	130	2	30867124
Pubmed	Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities.	MAP1LC3A USP10 KIRREL3	7.46e-05	22	130	3	34799561
Pubmed	The Hedgehog signalling pathway regulates autophagy.	MAP1LC3A BCL2	8.28e-05	4	130	2	23149744
Pubmed	Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet's disease.	AXL BCL2	8.28e-05	4	130	2	38648454
Pubmed	Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.	CPN1 C3	8.28e-05	4	130	2	11939578
Pubmed	Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain.	LGI2 LGI1	8.28e-05	4	130	2	19833108
Pubmed	The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.	MAP1LC3A BCL2	8.28e-05	4	130	2	25984893
Pubmed	ß3-integrin inhibits lipopolysaccharide-induced autophagy in cardiomyocytes via the Akt signaling pathway.	MAP1LC3A BCL2	8.28e-05	4	130	2	25824726
Pubmed	Phenotypic characterization of Ggt1(dwg/dwg) mice,a mouse model for hereditary γ-glutamyltransferase deficiency.	GGTLC2 GGT1	1.38e-04	5	130	2	23615310
Pubmed	gamma-glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function.	GGTLC2 GGT1	1.38e-04	5	130	2	11003618
Pubmed	Gamma-glutamyl transpeptidase gene organization and expression: a comparative analysis in rat, mouse, pig and human species.	GGTLC2 GGT1	1.38e-04	5	130	2	10392451
Pubmed	Hyperoxia-induced lung injury in gamma-glutamyl transferase deficiency is associated with alterations in nitrosative and nitrative stress.	GGTLC2 GGT1	1.38e-04	5	130	2	19850887
Pubmed	MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner.	MAP1LC3A BCL2	1.38e-04	5	130	2	21139567
Pubmed	Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice.	GGTLC2 GGT1	1.38e-04	5	130	2	12810527
Pubmed	Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice.	GGTLC2 GGT1	1.38e-04	5	130	2	8755578
Pubmed	Reproductive defects in gamma-glutamyl transpeptidase-deficient mice.	GGTLC2 GGT1	1.38e-04	5	130	2	11089562
Pubmed	N-acetyl-cysteine prevents age-related hearing loss and the progressive loss of inner hair cells in γ-glutamyl transferase 1 deficient mice.	GGTLC2 GGT1	1.38e-04	5	130	2	26977590
Pubmed	Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia.	GGTLC2 GGT1	1.38e-04	5	130	2	12225953
Pubmed	Identification of a sixth promoter that directs the transcription of gamma-glutamyl transpeptidase type III RNA in mouse.	GGTLC2 GGT1	1.38e-04	5	130	2	7775425
Pubmed	Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility.	GGTLC2 GGT1	1.38e-04	5	130	2	9139708
Pubmed	Analysis of site-specific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue.	GGTLC2 GGT1	1.38e-04	5	130	2	20622017
Pubmed	Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice.	GGTLC2 GGT1	1.38e-04	5	130	2	9546365
Pubmed	gamma-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions?	GGTLC2 GGT1	1.38e-04	5	130	2	7485380
Pubmed	Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase.	GGTLC2 GGT1	1.38e-04	5	130	2	10751614
Pubmed	Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine.	GGTLC2 GGT1	1.38e-04	5	130	2	7523374
Pubmed	Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase.	GGTLC2 GGT1	1.38e-04	5	130	2	24698228
Pubmed	Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.	STAT4 TNPO3	1.38e-04	5	130	2	20383147
Pubmed	gamma-Glutamyl transferase (GGT) deficiency in the GGTenu1 mouse results from a single point mutation that leads to a stop codon in the first coding exon of GGT mRNA.	GGTLC2 GGT1	1.38e-04	5	130	2	10474818
Pubmed	Lung lining fluid glutathione attenuates IL-13-induced asthma.	GGTLC2 GGT1	1.38e-04	5	130	2	18063838
Pubmed	Gamma-glutamyltranspeptidase knockout mice as a model for understanding the consequences of diminished glutathione on T cell-dependent immune responses.	GGTLC2 GGT1	1.38e-04	5	130	2	10940879
Pubmed	Cataract development in gamma-glutamyl transpeptidase-deficient mice.	GGTLC2 GGT1	1.38e-04	5	130	2	11095909
Pubmed	Expression of gamma-glutamyl transpeptidase in midgestation mouse yolk sac and mouse visceral yolk sac carcinoma cells.	GGTLC2 GGT1	1.38e-04	5	130	2	7641802
Pubmed	The mouse skin carcinogenesis model.	GGTLC2 GGT1	1.38e-04	5	130	2	9627710
Pubmed	Gamma-glutamyl transpeptidase and its role in melanogenesis: redox reactions and regulation of tyrosinase.	GGTLC2 GGT1	1.38e-04	5	130	2	12453183
Pubmed	Immunocytochemical localization of gamma-glutamyltranspeptidase during fetal development of mouse kidney.	GGTLC2 GGT1	1.38e-04	5	130	2	2891746
Pubmed	Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.	NDOR1 STAT4	1.38e-04	5	130	2	20231889
Pubmed	Liver-Specific Overexpression of Gamma-Glutamyltransferase Ameliorates Insulin Sensitivity of Male C57BL/6 Mice.	GGTLC2 GGT1	1.38e-04	5	130	2	28660214
Pubmed	Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.	GGTLC2 GGT1	1.38e-04	5	130	2	12468440
Pubmed	Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene.	GGTLC2 GGT1	1.38e-04	5	130	2	8566783
Pubmed	Therapeutic Effect of GGsTop, Selective Gamma-glutamyl Transpeptidase Inhibitor, on a Mouse Model of 5-Fluorouracil-induced Oral Mucositis.	GGTLC2 GGT1	1.38e-04	5	130	2	30591459
Pubmed	In vivo reversal of glutathione deficiency and susceptibility to in vivo dexamethasone-induced apoptosis by N-acetylcysteine and L-2-oxothiazolidine-4-carboxylic acid, but not ascorbic acid, in thymocytes from gamma-glutamyltranspeptidase-deficient knockout mice.	GGTLC2 GGT1	1.38e-04	5	130	2	11795900
Pubmed	Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.	GGTLC2 GGT1	1.38e-04	5	130	2	25132819
Pubmed	Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene.	GGTLC2 GGT1	1.38e-04	5	130	2	19760322
Pubmed	Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells.	GGTLC2 GGT1 ROBO2	1.74e-04	29	130	3	22424930
Pubmed	Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.	GGTLC2 GGT1	2.06e-04	6	130	2	14634009
Pubmed	Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse.	GGTLC2 GGT1	2.06e-04	6	130	2	8101000
Pubmed	Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes.	GGTLC2 GGT1	2.06e-04	6	130	2	8104871
Pubmed	Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response.	GGTLC2 GGT1	2.06e-04	6	130	2	11463821
Pubmed	Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.	GGTLC2 GGT1	2.06e-04	6	130	2	25326709
Pubmed	Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis.	STAT4 TNPO3	2.06e-04	6	130	2	23053960
Pubmed	Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo.	GGTLC2 GGT1	2.06e-04	6	130	2	12163373
Pubmed	Ablation of Mrds1/Ofcc1 induces hyper-γ-glutamyl transpeptidasemia without abnormal head development and schizophrenia-relevant behaviors in mice.	GGTLC2 GGT1	2.06e-04	6	130	2	22242126
Pubmed	Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis.	GGTLC2 GGT1	2.06e-04	6	130	2	17363454
Pubmed	A common protein interaction domain links two recently identified epilepsy genes.	LGI2 LGI1	2.06e-04	6	130	2	12095917
Pubmed	Four distinct membrane-bound dipeptidase RNAs are differentially expressed and show discordant regulation with gamma-glutamyl transpeptidase.	GGTLC2 GGT1	2.06e-04	6	130	2	8663190
Pubmed	The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders.	LGI2 LGI1	2.06e-04	6	130	2	12217514
Pubmed	Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.	STAT4 TNPO3	2.06e-04	6	130	2	20861858
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SIPA1L3 ADCY9 C2CD2L SCAP PHLPP1 UNC80	2.10e-04	225	130	6	12168954
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	SIPA1L3 SAV1 CLASP2 FRYL TSPYL1 USP10 STRN FAM193A	2.86e-04	446	130	8	24255178
Pubmed	Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.	GGTLC2 GGT1	2.88e-04	7	130	2	32284594
Pubmed	PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.	CPN1 GGT1	2.88e-04	7	130	2	20648472
Pubmed	m6A eraser FTO modulates autophagy by targeting SQSTM1/P62 in the prevention of canagliflozin against renal fibrosis.	GGTLC2 GGT1	2.88e-04	7	130	2	36685533
Pubmed	γ-Glutamyltranspeptidase is an endogenous activator of Toll-like receptor 4-mediated osteoclastogenesis.	GGTLC2 GGT1	2.88e-04	7	130	2	27775020
Pubmed	The claw paw mutation reveals a role for Lgi4 in peripheral nerve development.	LGI2 LGI1	2.88e-04	7	130	2	16341215
Pubmed	Advances in the understanding of skeletal muscle weakness in murine models of diseases affecting nerve-evoked muscle activity, motor neurons, synapses and myofibers.	MAP1LC3A BCL3	2.88e-04	7	130	2	25042397
Pubmed	Defective epidermal growth factor gene expression in mice with polycystic kidney disease.	GGTLC2 GGT1	2.88e-04	7	130	2	1968405
Pubmed	A new approach to the study of haematopoietic development in the yolk sac and embryoid bodies.	TBC1D8 CSF2RB	2.88e-04	7	130	2	7588067
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CLASP2 FRYL PHLPP1 DENND5A	3.26e-04	87	130	4	12465718
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	BOC FCRL2 PCDH12 TAOK2 KIRREL3 ST6GALNAC3 ITPRIP IGSF9B UGT3A2 FLRT2 YME1L1 LGI1	3.37e-04	985	130	12	12975309
Pubmed	The transcription factor XBP1 is selectively required for eosinophil differentiation.	STAT4 SIGLEC7 CSF2RB	3.61e-04	37	130	3	26147683
Pubmed	Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.	AFF3 STAT4 TNPO3	3.61e-04	37	130	3	20453842
Pubmed	Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.	STAT4 TNPO3	3.83e-04	8	130	2	21750679
Pubmed	Netrins and neogenin promote myotube formation.	BOC NEO1	3.83e-04	8	130	2	15520228
Pubmed	Identifying key genes related to inflammasome in severe COVID-19 patients based on a joint model with random forest and artificial neural network.	AXL BCL2	3.83e-04	8	130	2	37113134
Pubmed	Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.	USP10 PARP4 SCAP	4.90e-04	41	130	3	8724849
Pubmed	Embryonic Microglia Interact with Hypothalamic Radial Glia during Development and Upregulate the TAM Receptors MERTK and AXL following an Insult.	FCRL2 AXL	4.91e-04	9	130	2	33406432
Pubmed	Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.	VEGFC NDOR1	4.91e-04	9	130	2	27159393
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	BOC FSTL4 VSIG10 CADM2 KIRREL3 NEO1 PXDN ROBO2 IGSF9B	1.18e-07	161	91	9	593
GeneFamily	Fibronectin type III domain containing	BOC AXL NEO1 CSF2RB ATF7IP ROBO2 IGSF9B FLRT2	1.44e-06	160	91	8	555
GeneFamily	Immunoglobulin like domain containing	BOC FCRL2 AXL FSTL4 VSIG10 KIRREL3 NEO1 IGSF9B	5.81e-06	193	91	8	594
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	CPAMD8 C3	8.82e-04	9	91	2	1234
GeneFamily	Adenosine receptors\|V-set domain containing	AXL VSIG10 CADM2 SIGLEC7 IGSF9B	1.40e-03	163	91	5	590
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH12	1.60e-03	12	91	2	21
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGTLC2 GGT1	1.89e-03	13	91	2	564
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	VEGFC FRYL ADCY9 STRN VPS13A PHLPP1 SPEN TMCC1 DOP1A	1.96e-05	300	130	9	M8702
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	NDOR1 CNTRL FSTL4 PHC3 PAN2 MICAL3 NXF1	1.98e-05	166	130	7	M6826
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	VEGFC PARG CLASP2 FRYL VPS13A PHLPP1 PDS5A MICAL3 DENND5A SPEN MED13	2.17e-05	466	130	11	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	VEGFC PARG CLASP2 FRYL ADCY9 FAM193A VPS13A PHLPP1 PDS5A MICAL3 FLRT2 DENND5A SPEN TMCC1 MED13	2.34e-05	856	130	15	M4500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000	MED14 CLASP2 STRN LGI2 GALNT5 MED13 LGI1	3.69e-05	151	128	7	gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	MED14 CLASP2 FAM193A NUP155 SCMH1 VPS13A ROBO2 MED13	4.01e-05	209	128	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	BCL2 FIGN CADM2 KIRREL3 AEBP1 ROBO2 C3 MYRF	4.23e-08	172	130	8	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EFCAB13 BCL2 ITGA3 FIGN CADM2 KIRREL3 IGSF9B	1.36e-06	188	130	7	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EFCAB13 BCL2 ITGA3 FIGN CADM2 KIRREL3 IGSF9B	1.36e-06	188	130	7	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFF3 FSTL4 ITGA3 RGS6 PXDN ST6GALNAC3 PHLPP1	1.46e-06	190	130	7	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	BOC HIPK4 HIVEP3 NEO1 ROBO2 MICAL3 SMTNL2	1.51e-06	191	130	7	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	FRYL LRRC58 STRN MBTPS2 SBF2 PDS5A MED13	1.62e-06	193	130	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC AXL NEO1 LGI2 AEBP1 C3 FLRT2	1.62e-06	193	130	7	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 FSTL4 PCDH12 RGS6 PXDN ST6GALNAC3 ITPRIP	1.99e-06	199	130	7	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	BOC SAV1 LRRC58 PXDN PHLPP1 PDS5A DENND5A	1.99e-06	199	130	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	CLASP2 ITGA3 KIRREL3 TMEM132E IGSF9B UNC80	7.10e-06	158	130	6	1f94622186d8329357fa06785e03eeacf29ab1ce
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO19 FRYL BCL2 STAT4 DDIAS PAN2	7.91e-06	161	130	6	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	FCRL2 MMS22L ASAP3 DDIAS HROB FLRT2	9.42e-06	166	130	6	f4698fd08965936d51695d571bd10fb77330d916
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BCL2 ITGA3 CADM2 KIRREL3 MICAL3 MYRF	1.01e-05	168	130	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GABRB2 HIPK4 MYO19 CADM2 DDIAS FLRT2	1.19e-05	173	130	6	b43817a6b1ed8d6b5366702343be4311c0d52d83
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-stromal_related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC ASAP3 TEX10 FIGN C3 FLRT2	1.27e-05	175	130	6	b8995e7ada85ba959f06264a0295b61e390c4e6c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC ASAP3 TEX10 FIGN C3 FLRT2	1.27e-05	175	130	6	7ae76bd3b4f610b2f98716a4456437cd3696b686
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	AXL BCL2 KIRREL3 PXDN AEBP1 C3	1.45e-05	179	130	6	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	Control-Lymphoid-B\|World / Disease state, Lineage and Cell class	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	1.54e-05	181	130	6	9124f1a610cfc3355ad87921cd3eb5346956475d
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	1.54e-05	181	130	6	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	1.69e-05	184	130	6	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	Control-Lymphoid-B\|Control / Disease state, Lineage and Cell class	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	1.69e-05	184	130	6	de0294f879268bfd68e91adcc2adba211d221b7a
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	1.69e-05	184	130	6	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|tumor_Lung / Location, Cell class and cell subclass	GABRB2 BOC C3 FLRT2 MYRF SMTNL2	1.69e-05	184	130	6	b0a251030d127858e68cf164be158f209a4d720f
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	1.74e-05	185	130	6	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	SIPA1L3 VSIG10 ABCC6 TBC1D8 SCMH1 MED13	1.80e-05	186	130	6	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SIPA1L3 VSIG10 ABCC6 TBC1D8 SCMH1 MED13	1.80e-05	186	130	6	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	1.91e-05	188	130	6	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC ASAP3 ERVMER34-1 ADCY9 ROBO2 SMTNL2	2.02e-05	190	130	6	81f8f2cddf4c51b879f315260cd1fca80355a371
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC ASAP3 ERVMER34-1 ADCY9 ROBO2 SMTNL2	2.02e-05	190	130	6	20106e5213f6a7560554b8b4f84b23c5554ba975
ToppCell	human_hepatoblastoma-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	VEGFC BOC HIVEP3 PXDN ST6GALNAC3 ITPRIP	2.02e-05	190	130	6	8d6ef93d69e96cd6921816d152bea3b0710cf147
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VEGFC BOC ASAP3 PXDN C3 FLRT2	2.02e-05	190	130	6	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	BOC ASAP3 ERVMER34-1 ADCY9 ROBO2 SMTNL2	2.02e-05	190	130	6	877b544decf302e0d41be23dffa1861f79c70914
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA3 AEBP1 C3 FLRT2 MYRF SMTNL2	2.09e-05	191	130	6	5343a527de6b0f852f45020a91f5b4869e78f13a
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA3 AEBP1 C3 FLRT2 MYRF SMTNL2	2.09e-05	191	130	6	a25a5f9a380031fdaf57677a079f97a90f0550c0
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FCRL2 SIPA1L3 AFF3 SAV1 BCL2 MICAL3	2.09e-05	191	130	6	5a9a592875fbd0b1429b48db29a760fdc9c2c856
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	2.15e-05	192	130	6	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GABRB2 AXL P4HA3 LGI2 AEBP1 C3	2.15e-05	192	130	6	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VEGFC BOC PCDH11Y TBC1D8 ST6GALNAC3 ITPRIP	2.15e-05	192	130	6	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC AXL LGI2 AEBP1 C3 FLRT2	2.15e-05	192	130	6	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	AFF3 FSTL4 ITGA3 PCDH12 RGS6 PXDN	2.15e-05	192	130	6	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC AXL LGI2 AEBP1 C3 FLRT2	2.15e-05	192	130	6	7b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BOC AXL LGI2 AEBP1 C3 FLRT2	2.15e-05	192	130	6	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	VEGFC BOC HIVEP3 PXDN ST6GALNAC3 ITPRIP	2.15e-05	192	130	6	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC AXL LGI2 AEBP1 C3 FLRT2	2.15e-05	192	130	6	32acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCRL2 AFF3 BCL2 ATF7IP VPS13A MICAL3	2.21e-05	193	130	6	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BCL2 GGTLC2 FIGN PARP4 LGI2 AEBP1	2.21e-05	193	130	6	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC BOC PCDH12 ST6GALNAC3 ITPRIP FLRT2	2.28e-05	194	130	6	cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AXL AFF3 FIGN PXDN AEBP1 FLRT2	2.28e-05	194	130	6	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	AXL KIRREL3 PXDN AEBP1 C3 FLRT2	2.28e-05	194	130	6	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AXL AFF3 FIGN PXDN AEBP1 FLRT2	2.28e-05	194	130	6	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCRL2 SIPA1L3 AFF3 BCL2 ATF7IP MICAL3	2.34e-05	195	130	6	0c49d22c348aec6d8a1a976e7c88d0a3b48a4244
ToppCell	background-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	CYP2E1 PXDN ST6GALNAC3 ITPRIP C3 FLRT2	2.34e-05	195	130	6	c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BOC AFF3 FIGN AEBP1 C3 FLRT2	2.34e-05	195	130	6	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	SIPA1L3 AFF3 ADCY9 HIVEP3 SCMH1 TMCC1	2.41e-05	196	130	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GABRB2 MMS22L ARHGAP40 KSR2 HROB MYRF	2.48e-05	197	130	6	49689a03ab31e53386dbe15c77c09ca3a14ebf4e
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA3 ABCC6 GGT1 ESYT3 GALNT5 MYRF	2.63e-05	199	130	6	aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	AFF3 ITGA3 PCDH12 ERVMER34-1 PXDN ITPRIP	2.63e-05	199	130	6	1621ce2968f3100e4c39e0ef8293232a5d76c614
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	GABRB2 BOC C3 FLRT2 MYRF SMTNL2	2.63e-05	199	130	6	ca970114b5aef4518ce580897a62ac88688b2671
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BOC FBXO17 FIGN PXDN AEBP1 FLRT2	2.63e-05	199	130	6	21335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCell	distal-2-mesenchymal-Myofibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BOC P4HA3 AEBP1 ROBO2 FLRT2 SMTNL2	2.63e-05	199	130	6	b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AXL RGS6 PXDN AEBP1 MICAL3 IGSF9B	2.63e-05	199	130	6	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FCRL2 SIPA1L3 AFF3 SAV1 ATF7IP MICAL3	2.70e-05	200	130	6	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BOC LGI2 AEBP1 C3 FLRT2 SMTNL2	2.70e-05	200	130	6	d64895354218ebd0217011bae0967a6883bbd1cd
ToppCell	Goblet-gob-2\|World / Class top	VEGFC BARX2 CADM2 GGT1 LGI2	6.09e-05	142	130	5	9b058dc313d1f0edcd8473e342852632e17536a6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UGT3A1 HROB CSF2RB ST6GALNAC3 TACC3	6.50e-05	144	130	5	f501e11b1d051ca67124137017a79a2d5bb6ae87
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PCDH11Y TAOK2 KIRREL3 RGS6 FLRT2	6.50e-05	144	130	5	748f4efc59f7afbce6c497524f36d852b8b1d637
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYP2E1 PCDH12 FIGN CADM2 UNC80	7.17e-05	147	130	5	2d9044ddf01b6838a44a4518b442d7e7cb0bf910
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 UGT3A1 KSR2 FRMPD1 ROBO2	7.17e-05	147	130	5	64fa0753a3a79f492ef8acc6942bf90d379a983f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EFCAB13 CADM2 KIRREL3 C3 IGSF9B	7.17e-05	147	130	5	989a48bda98fbff398985397a6b1189a4cbc80e7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EFCAB13 CADM2 KIRREL3 C3 IGSF9B	7.17e-05	147	130	5	f6681c849c4c06154548bd29a094f202d1c946c2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA3 CADM2 KIRREL3 AEBP1 IGSF9B	9.49e-05	156	130	5	dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA3 CADM2 KIRREL3 AEBP1 IGSF9B	9.49e-05	156	130	5	abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	AFF3 FSTL4 ITGA3 PCDH12 RGS6	9.78e-05	157	130	5	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF3 AK8 CADM2 TBC1D8 CSF2RB	1.07e-04	160	130	5	237430af14830b38e58da8a4224036e5c6b71c5b
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXW10 CNTRL BCL2 GGT1 STAT4	1.10e-04	161	130	5	140b3c7077947c541cff54f6754e2df968345f4d
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma\|TCGA-Brain / Sample_Type by Project: Shred V9	CDHR1 AFF3 KSR2 FRMPD1 UNC80	1.10e-04	161	130	5	5f6b2d7f80a8ee16651e304481d2da3fae313824
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UGT3A1 KSR2 FRMPD1 FSTL4 BARX2	1.13e-04	162	130	5	285e6d553f485fd9f1075c4e1b940da251b5ea35
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXW10 CNTRL BCL2 GGT1 STAT4	1.13e-04	162	130	5	16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UGT3A1 KSR2 FRMPD1 FSTL4 BARX2	1.20e-04	164	130	5	6fb2136168f430babfeb81ca7e151ca7a8092ec4
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRB2 BOC C3 FLRT2 MYRF	1.20e-04	164	130	5	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	AFF3 EFCAB13 KIRREL3 MICAL3 GALNT5	1.23e-04	165	130	5	8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BOC BCL2 AEBP1 ANKRD61 ROBO2	1.27e-04	166	130	5	94636dbc039f794c735960c3425e00bdd5523602
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRDX4 ZNF200 BCL3 LGI2 ROBO2	1.31e-04	167	130	5	b4ef07117d14da3d5fbced949e4dfcb01c392295
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BCL3 CADM2 AEBP1 SCNN1D SMTNL2	1.31e-04	167	130	5	f4943fb5001475ddab82a0273bcbb3fa68fdd7bd
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRDX4 ZNF200 BCL3 LGI2 ROBO2	1.31e-04	167	130	5	94fc7df7ca55cd722a8dbd153201a29891217473
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRDX4 ZNF200 BCL3 LGI2 ROBO2	1.31e-04	167	130	5	eff3723fe60755272eca237459165e436e919ece
ToppCell	facs-Kidney\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP2E1 UGT3A1 CPN1 GGT1 UGT3A2	1.34e-04	168	130	5	d2f17a470e04f8f0edb111894027bcfc6ee1a12f
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive\|lymph-node_spleen / Manually curated celltypes from each tissue	BOC FCRL2 AFF3 HIVEP3 MICAL3	1.34e-04	168	130	5	494d5a11154ff22fedb25f4036d730cef376da60
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	AXL DDIAS HROB SIGLEC7 HEXA-AS1	1.38e-04	169	130	5	818ab7a6fd1940a22d3bd99fe15f0af888af6b3e
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	AFF3 ITGA3 PCDH12 STAT4 RGS6	1.38e-04	169	130	5	225aec04ba762d4c55885257de03a65b63503fbb
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	AXL DDIAS HROB SIGLEC7 HEXA-AS1	1.38e-04	169	130	5	f982f2e0d341fa27229f443ebe5c0e4a9e63bda6
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	AFF3 ITGA3 PCDH12 STAT4 RGS6	1.38e-04	169	130	5	278960f940b646a788360b1c84d641a8d169896b
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CPAMD8 ARHGAP40 AFF3 RSPH6A ITGA3	1.42e-04	170	130	5	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BOC LGI2 CFAP206 C3 FLRT2	1.42e-04	170	130	5	7653f1205d4e62abe7e31b1d76f9bbd665e45667
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCRL2 SIPA1L3 AFF3 EFCAB13 BCL2	1.46e-04	171	130	5	c3e3ea09c73050372314a89b282e36ba5f339d73
ToppCell	P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FIGN CADM2 MLIP UNC80 LGI1	1.50e-04	172	130	5	8d6a2a0d5f63b09a5a304a77e600a647f87e9de4
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FCRL2 AFF3 SAV1 ATF7IP MICAL3	1.50e-04	172	130	5	62ed3b70fa1f6c84ea80ff00f60d2562be292e9d
ToppCell	10x5'-Lung-Lymphocytic_B-Memory_B_cells\|Lung / Manually curated celltypes from each tissue	BOC FCRL2 AFF3 AEBP1 MICAL3	1.50e-04	172	130	5	2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIPK4 AK8 TBC1D8 CSF2RB SLC27A1	1.50e-04	172	130	5	30916a902c151907745756d14327e24adc34afef
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	BOC TEX10 ZNF600 PAN2 NXF1	1.54e-04	173	130	5	d4cbeae262abfa30d8c5452285d3261a96875610
Drug	Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; PC3; HT_HG-U133A	FRMPD1 MED14 PCDH12 TAOK2 HIVEP3 PHC3 MBTPS2 VPS13A TMCC1 CAPN15	2.17e-07	200	129	10	4625_DN
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	AFF3 STAT4 HIVEP3 FAM193A CSF2RB MYRF SMTNL2	7.96e-06	170	124	7	EFO_0000685, EFO_0007791, EFO_0007837
Disease	non-obstructive coronary artery disease	BCL2 PHLPP1	1.05e-04	4	124	2	EFO_1001483
Disease	X-24544 measurement	UGT3A1 UGT3A2	1.05e-04	4	124	2	EFO_0800892
Disease	rheumatoid arthritis	AFF3 FSTL4 STAT4 TBC1D8 FAM193A CSF2RB MYRF TNPO3 SMTNL2	1.52e-04	462	124	9	EFO_0000685
Disease	Anterior segment mesenchymal dysgenesis	CPAMD8 PXDN	1.74e-04	5	124	2	C1862839
Disease	migraine disorder, endometriosis	FSTL4 BCL2 SBF2 ROBO2	2.58e-04	73	124	4	EFO_0001065, MONDO_0005277
Disease	Lymphoma, Non-Hodgkin	CYP2E1 BCL2 SPEN	3.29e-04	32	124	3	C0024305
Disease	cognitive function measurement	GABRB2 MMS22L AFF3 FSTL4 BCL2 BARX2 FIGN CADM2 FAM193A SCMH1 ST6GALNAC3 ATF7IP PHLPP1 PDS5A IGSF9B UGT3A2	3.42e-04	1434	124	16	EFO_0008354
Disease	cholesteryl ester 18:2 measurement	FSTL4 BCL3 MYRF	3.60e-04	33	124	3	EFO_0010345
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGTLC2 GGT1	3.63e-04	7	124	2	DOID:5022 (biomarker_via_orthology)
Disease	alcohol dependence (biomarker_via_orthology)	GGTLC2 GGT1	4.82e-04	8	124	2	DOID:0050741 (biomarker_via_orthology)
Disease	Anterior segment dysgenesis	CPAMD8 PXDN	4.82e-04	8	124	2	cv:C1862839
Disease	serum gamma-glutamyl transferase measurement	AXL SIPA1L3 ASAP3 BCL2 CPN1 GGT1 TBC1D8 STRN MLIP C3 MICAL3 MED13	4.83e-04	914	124	12	EFO_0004532
Disease	eosinophil count	SIPA1L3 BCL2 RSPH6A BCL3 FBXO17 AK8 STAT4 HIVEP3 PHC3 FAM193A PXDN CSF2RB ATF7IP SBF2 UGT3A2 MYRF	5.12e-04	1488	124	16	EFO_0004842
Disease	anti-centromere-antibody-positive systemic scleroderma	STAT4 TNPO3	6.19e-04	9	124	2	EFO_0008536
Disease	Moyamoya disease	FSTL4 SBF2 MYRF	6.39e-04	40	124	3	MONDO_0016820
Disease	schizophrenia, intelligence, self reported educational attainment	MMS22L AFF3 CADM2 TAOK2 RGS6 ATF7IP IGSF9B	6.69e-04	346	124	7	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	venous thromboembolism, von Willebrand factor measurement	AK8 KIRREL3 MYRF	7.38e-04	42	124	3	EFO_0004286, EFO_0004629
Disease	Colorectal Carcinoma	BOC CPAMD8 ASAP3 BCL2 ABCC6 HIVEP3 SIGLEC7 VPS13A PAN2 UGT3A2	7.81e-04	702	124	10	C0009402
Disease	biliary liver cirrhosis	UGT3A1 STAT4 TNPO3	8.46e-04	44	124	3	EFO_0004267
Disease	serum non-albumin protein measurement	UGT3A1 AFF3 EFCAB13 BCL2 BCL3 PHLPP1 UGT3A2	8.57e-04	361	124	7	EFO_0004568
Disease	adipose tissue measurement	MMS22L ZNF600 ST6GALNAC3	9.04e-04	45	124	3	EFO_0004764
Disease	cysteine-glutathione disulfide measurement	FSTL4 GGT1	9.40e-04	11	124	2	EFO_0021001
Disease	intelligence, self reported educational attainment	MMS22L AFF3 FAM193A ATF7IP	1.53e-03	117	124	4	EFO_0004337, EFO_0004784
Disease	Diffuse Large B-Cell Lymphoma	PRDX4 BCL2 SPEN	1.62e-03	55	124	3	C0079744
Disease	revision of total joint arthroplasty, aseptic loosening	BCL2 PHLPP1	2.02e-03	16	124	2	EFO_0010725, EFO_0020974
Disease	HbA1c measurement	CPAMD8 NDOR1 AXL ADCY9 C2CD2L HROB AEBP1 SBF2 VPS13A	2.24e-03	675	124	9	EFO_0004541
Disease	plasma beta-amyloid 1-40 measurement	SAV1 PDS5A	2.29e-03	17	124	2	EFO_0005659
Disease	hypertrophic cardiomyopathy (is_marker_for)	MAP1LC3A BCL2	2.29e-03	17	124	2	DOID:11984 (is_marker_for)
Disease	glomerulonephritis (implicated_via_orthology)	AXL C3	2.29e-03	17	124	2	DOID:2921 (implicated_via_orthology)
Disease	neuroticism measurement, cognitive function measurement	MMS22L MAP1LC3A FIGN CADM2 STRN SCAP FAM193A IGSF9B	2.75e-03	566	124	8	EFO_0007660, EFO_0008354
Disease	familial hyperlipidemia (biomarker_via_orthology)	CYP2E1 SLC27A1	2.86e-03	19	124	2	DOID:1168 (biomarker_via_orthology)
Disease	limited scleroderma	STAT4 TNPO3	2.86e-03	19	124	2	EFO_1001017
Disease	insulin sensitivity measurement, body mass index	ARHGAP40 BCL2	2.86e-03	19	124	2	EFO_0004340, EFO_0004471
Disease	biological sex	AFF3 FIGN AK8 CADM2 IGSF9B	2.93e-03	230	124	5	PATO_0000047
Disease	sporadic amyotrophic lateral sclerosis	FSTL4 RGS6 TMEM132E ST6GALNAC3	2.93e-03	140	124	4	EFO_0001357
Disease	hip circumference	GABRB2 ADCY9 CADM2 KIRREL3 TMEM132E ROBO2	3.11e-03	338	124	6	EFO_0005093
Disease	neoplasm of mature B-cells	BCL2 PHLPP1	3.17e-03	20	124	2	EFO_0000096
Disease	Lymphoma, Diffuse	CYP2E1 BCL2	3.49e-03	21	124	2	C3714542
Disease	Low Grade Lymphoma (neoplasm)	CYP2E1 BCL2	3.49e-03	21	124	2	C0079747
Disease	Lymphoma, Intermediate-Grade	CYP2E1 BCL2	3.49e-03	21	124	2	C0079741
Disease	High Grade Lymphoma (neoplasm)	CYP2E1 BCL2	3.49e-03	21	124	2	C0079740
Disease	Diffuse Mixed-Cell Lymphoma	CYP2E1 BCL2	3.49e-03	21	124	2	C0079757
Disease	Lymphoma, Undifferentiated	CYP2E1 BCL2	3.49e-03	21	124	2	C0024306
Disease	Reticulosarcoma	CYP2E1 BCL2	3.49e-03	21	124	2	C0024302
Disease	Lymphoma, Mixed-Cell	CYP2E1 BCL2	3.49e-03	21	124	2	C0024304
Disease	serum albumin measurement	VEGFC ASAP3 SAV1 BCL2 ADCY9 MLIP SBF2 MICAL3	3.61e-03	592	124	8	EFO_0004535
Disease	serum alanine aminotransferase measurement	EFCAB13 MAP1LC3A BCL2 CPN1 BARX2 TBC1D8 STRN MLIP ST6GALNAC3 MYRF	3.72e-03	869	124	10	EFO_0004735
Disease	triacylglycerol 58:9 measurement	TMEM132E MYRF	3.83e-03	22	124	2	EFO_0010443
Disease	Lymphoma, Non-Hodgkin, Familial	CYP2E1 BCL2	3.83e-03	22	124	2	C4721532
Disease	Lymphoma, Small Noncleaved-Cell	CYP2E1 BCL2	3.83e-03	22	124	2	C0079770
Disease	amyloid-beta measurement	BOC AFF3 STAT4 KIRREL3 MICAL3 DENND5A	3.96e-03	355	124	6	EFO_0005194
Disease	cognitive function measurement, self reported educational attainment	MMS22L AFF3 CADM2 FAM193A SCMH1 IGSF9B	3.96e-03	355	124	6	EFO_0004784, EFO_0008354

Protein segments in the cluster

Peptide	Gene	Start	Entry
RILVNTPSPLVTGLH	nan	6	Q9HAA7
ALSPSTIVSIPQRIH	AFF3	1141	P51826
IATHLVLPNRVTVPV	ESYT3	276	A0FGR9
HSTINRPPVKLTLLT	ASAP3	336	Q8TDY4
TVPVTIRIVDLNNHP	CDHR1	336	Q96JP9
ISLILVENPVVTLPH	CNTRL	221	Q7Z7A1
LVQDTRIHLVPSLNP	AEBP1	656	Q8IUX7
KISLHSPRVQSTIPQ	FBXW10	896	Q5XX13
INTHPSQKPLSITVR	C3	411	P01024
ATTKRRHQQTVTIPP	C3	876	P01024
ESLRLPQVPTLHSQV	DOP1A	2206	Q5JWR5
VLLRNHPVNQPITIL	ANKRD61	46	A6NGH8
VTARPEQSQILIQHP	ATF7	286	P17544
NQTHPTIAILPTSRK	DCLRE1B	246	Q9H816
PITIQQHPRLILTDS	FAM193A	271	P78312
RVTPPISERIQLSIH	FLRT2	416	O43155
STQTNTHILPPTIVR	CFAP206	516	Q8IYR0
FVPTVRRLPTHTQLA	MLIP	36	Q5VWP3
TDLPQIRSTLIPILH	PDS5A	711	Q29RF7
QAQSPVHVLSQPIRK	RGS6	241	P49758
EIQRFITLVPSNLPH	CYP2E1	356	P05181
VVVTAIINHPLLFPR	ITPRIP	11	Q8IWB1
VIQRPNIPHLQTRDT	P4HA3	286	Q7Z4N8
SPPVQQISQLLSLLH	PCDH12	956	Q9NPG4
DSVPPLHRQVLVILS	CAPN15	1021	O75808
QPTIQTRNIRHLPDI	PAN2	726	Q504Q3
PLPDSTARHQIIVQL	FIGN	651	Q5HY92
ILTLPAVQHIALVPT	KLHL33	511	A6NCF5
LKAVHSPIRSQPVTL	MICAL3	1216	Q7RTP6
APLPARHIRTVTLQV	HIPK4	106	Q8NE63
RQLIQTPLHDSLPIT	SBF2	181	Q86WG5
PLIQDILHTLPVLTQ	MYO19	706	Q96H55
QHPVLLALRNTATIP	MMS22L	1046	Q6ZRQ5
LVQPQHLLAPVFRTL	ERVMER34-1	21	Q9H9K5
TRAPQVILHPVTSNP	KSR2	586	Q6VAB6
IQTLGITPRHVIVLS	AK8	151	Q96MA6
INIVHKTLVPRPAVL	ITGA3	466	P26006
RISIIINSSAPPHTI	NXF1	186	Q9UBU9
LPLLRPSANHTVTIR	PARG	471	Q86W56
VSIPRPHLLTQVKAI	FAM205A	661	Q6ZU69
VSIPRPHLLTQVKAI	FAM205BP	391	Q63HN1
ALHTPPIALRSSQVI	DDIAS	471	Q8IXT1
IIQNVPVHQRRSIFP	FRYL	1051	O94915
LPVPTALTVPTQQLH	HROB	251	Q8N3J3
TTINTHLRETLPKIP	GABRB2	286	P47870
PRLHNQLLPNVTTVE	GGTLC2	151	Q14390
LQPISTVSPLHRVLH	PARP4	1706	Q9UKK3
VVSVLNTILTPLLNP	OR6X1	271	Q8NH79
PSQSPTIIIHPQALI	PHC3	406	Q8NDX5
IQSIPPQLSQLHSLR	LRRC58	201	Q96CX6
LTHPSRLQILVAVVQ	NDOR1	391	Q9UHB4
RQPLARPNTLTLVHV	NUP155	376	O75694
NQILRHRLVTTDLPP	MED14	196	O60244
RVPLIPVLLNVLHNV	OR56B2P	276	Q8NGI1
LVQVLSHVPPRSLVT	FBXO17	26	Q96EF6
TRLTVTLTQHVQPPE	CSF2RB	121	P32927
SVQPPSLHVLEQRLR	GUK1	121	Q16774
HAVVQLRTSRPSITP	BOC	401	Q9BWV1
VNFHLKRSIPQVSPV	CPN1	411	P15169
HVTLTLPPTQLEVNL	C2CD2L	181	O14523
NPTQTLIPVRHTVKI	FRMPD1	46	Q5SYB0
TLLRSVHSVINRSPP	GALNT5	511	Q7Z7M9
PLLSVITRQPTVISH	BARX2	71	Q9UMQ3
ITRQPTVISHLVPAT	BARX2	76	Q9UMQ3
PQHRVLISIFTVSPN	CPAMD8	141	Q8IZJ3
QTHVLQVNVPPVIRV	FSTL4	331	Q6MZW2
LIVHDVPNTLLPTTI	CADM2	311	Q8N3J6
IPQHQLSISPDIRVQ	ADCY9	1251	O60503
PLQQSPSVIRRLVTI	DENND5A	1081	Q6IQ26
LQVQQHSKRTEIIPP	EFCAB13	91	Q8IY85
LPVILHVPVAVSSQP	ATF7IP	781	Q6VMQ6
TQISHILDRQLPRLP	IFRD2	316	Q12894
TTHLQLISPVQQLRI	MBTPS2	206	O43462
SVTIDIQHPPLVNLS	KIRREL3	241	Q8IZU9
HVPIQSKVVNIPVRI	FCRL2	281	Q96LA5
LRQTPLHLAVITTLP	BCL3	171	P20749
ARQTVPPLTVRLHTQ	PWWP2B	461	Q6NUJ5
RQLAVRPSTPHTITL	SCAP	476	Q12770
VLRVEQQPHLPLLST	SCNN1D	471	P51172
RLTINLLVTTHIPFP	HEXA-AS1	26	Q9H8Q6
LTVTHNRLQTLPPAL	PIDD1	176	Q9HB75
IVLCHSPPVTQTIAL	PCDH11Y	1186	Q9BZA8
LVQSIVQTPSTLHLP	OR2H1	151	Q9GZK4
LPHVTPAQIVNARKI	RSPH6A	441	Q9H0K4
IQVTSLPPSQTPRVH	RTP3	166	Q9BQQ7
QINRVISHPTLPISI	STRN	666	O43815
TFQTPLRDPQTHRIL	TACC3	56	Q9Y6A5
PIRIPLLSDLTHQIS	PRDX4	171	Q13162
VRSHVPASQPVVQVL	TMEM132E	131	Q6IEE7
HLILSSRSQVPIILQ	LGI2	386	Q8N0V4
HTLRSRISIIPQDPI	ABCC6	1336	O95255
AQPAHVRVSIPLSIL	MIIP	276	Q5JXC2
VPSSLHVRPLVTSIV	NEO1	741	Q92859
HAQSLSRPLKQTPIV	SIPA1L3	1106	O60292
VNVTALTHRPNILIP	SIGLEC7	141	Q9Y286
RVVSHTSVPLLLKNP	ST6GALNAC3	126	Q8NDV1
NPRTTQHPLALLARV	TAOK2	1136	Q9UL54
TLPPHIKSTVSVQII	MED13	1676	Q9UHV7
QQIRDQHPSKIPVII	MAP1LC3A	21	Q9H492
PTNLVSTSQRHRPLL	SCMH1	516	Q96GD3
LSPVPPVVHLTLRQA	BCL2	86	P10415
RHTHVPRLIPLITSN	CLASP2	206	O75122
QSFLRTPIQRTPHEI	SAV1	71	Q9H4B6
SVILHSQPLSPAQRL	UGT3A1	441	Q6NUS8
VHSIIRRSLPATLPQ	VEGFC	221	P49767
TIRSPVQIRNHFSVP	VPS13A	1991	Q96RL7
PIISFLPHLRSLINV	UNC80	2626	Q8N2C7
LQTVINVLLPPRIIS	UNC80	2741	Q8N2C7
VPLTPSTKVAHVLRQ	ARHGAP40	536	Q5TG30
INTPPVLVHNQLVLT	SPEN	2936	Q96T58
QTIFRVPSPLVHIQL	TMPRSS7	446	Q7RTY8
HTIPRIFQAVVQRQP	SLC27A1	76	Q6PCB7
LHQVVLQPSRLSPLT	IGSF9B	1191	Q9UPX0
TPLQTHSIIISDQVP	TSPYL1	11	Q9H0U9
THPQRPLVLKTLIQF	STAT4	326	Q14765
SLLPHPIIVSIRSKV	TBC1D8	356	O95759
AKVVPQQITHTSPRI	SAP130	431	Q9H0E3
QKVVAHLTVQPRVTP	PXDN	511	Q92626
LVPLSVPRTQVIEHI	HIVEP3	451	Q5T1R4
ITVLPQQPRNLHLVS	AXL	221	P30530
VSLSLRLPHQPVTAI	SMTNL2	186	Q2TAL5
SLRGVPHVIQTQLSP	TEX10	701	Q9NXF1
PTHPTALNRVLQQIR	TMCC1	96	O94876
DVLVRLHNPVVLTPT	ROBO2	636	Q9HCK4
LHNPVVLTPTTVQVT	ROBO2	641	Q9HCK4
VSSSLQNRVHPRPLV	ZNF200	76	P98182
QRSPVTLLRSQVVIP	TNPO3	761	Q9Y5L0
STVQPQVTVPLSHLI	YME1L1	6	Q96TA2
ENVTLIHKPVSLQPR	USP10	401	Q14694
PEVIIQPSSRHLITQ	VSIG10	351	Q8N0Z9
VVPRPHVQSVLLTPQ	PHLPP1	1351	O60346
SVILRSHPLSPTQRL	UGT3A2	441	Q3SY77
VSTSQRISPRPQIHI	ZNF600	121	Q6ZNG1
VPTPITASLSHNRIR	TSEN15	106	Q8WW01
EPRLHNQLLPNVTTV	GGT1	501	P19440
LTPLHLQIDPTIQRV	KRT75	131	O95678
EIVRTPQTLRTPHLI	LGI1	386	O95970
QVNEPHLLRTITPET	MYRF	151	Q9Y2G1